Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0761-2
Full Text
Open PDFAbstract
Available in full text
Date
July 9, 2019
Authors
Publisher
Springer Science and Business Media LLC